SpyGlass Pharma, Inc.
Ownership
Ownership Structure
Who owns SpyGlass Pharma, Inc. (SGP)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 19.4% of the shares are freely tradable; institutional investors hold 95.5%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| RA Capital Management, LLC | 23.98 | 8,021,117 | +0.0 | 03/31/2026 |
| NEA Management Company, LLC | 22.10 | 7,392,301 | +0.0 | 03/31/2026 |
| Sands Capital Ventures, LLC | 7.47 | 2,500,012 | +0.0 | 06/30/2026 |
| Samsara BioCapital, LLC | 6.31 | 2,109,953 | +0.0 | 06/30/2026 |
| T. Rowe Price Associates, Inc. | 2.11 | 704,440 | +0.0 | 03/31/2026 |
| Vestal Point Capital LP | 1.99 | 666,760 | +0.0 | 03/31/2026 |
| JPMorgan Chase & Co | 1.73 | 577,109 | +0.0 | 03/31/2026 |
| Deerfield Management Co | 1.64 | 550,000 | +0.0 | 03/31/2026 |
| Millennium Management LLC | 1.52 | 507,257 | +8.2 | 06/30/2026 |
| Aberdeen Group PLC | 1.47 | 493,076 | +123.7 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.